Cbl-b-IN-9 structure
|
Common Name | Cbl-b-IN-9 | ||
|---|---|---|---|---|
| CAS Number | 2815223-41-5 | Molecular Weight | 566.62 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C30H33F3N6O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Cbl-b-IN-9Cbl-b-IN-9 (Compound 300) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.6 nM and 4.7 nM, respectively[1]. |
| Name | Cbl-b-IN-9 |
|---|
| Description | Cbl-b-IN-9 (Compound 300) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 5.6 nM and 4.7 nM, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 4.7 nM (c-Cbl), 5.6 nM (Cbl-b)[1] |
| References |
[1]. Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1. |
| Molecular Formula | C30H33F3N6O2 |
|---|---|
| Molecular Weight | 566.62 |